Floatz logo

1,379 assets in Cancer

Therapeutic assets addressing Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
zx-101a
Cancer
Nanjing Zenshine PharmaceuticalsP1/2CC (40)
177lu-im-3050
Cancer
Immunome, Inc.Early P1C (39)
[177lu]lu-dota-str-17126
Cancer
Integrated Haematology and Oncology NetworkEarly P1C (39)
[68ga]ga-dota-str-17126
Cancer
Integrated Haematology and Oncology NetworkEarly P1C (39)
ab598
Cancer
Arcus Biosciences, Inc.P1C (39)
ab801
Cancer
Arcus Biosciences, Inc.P1C (39)
abl501
Cancer
ABL Bio, Inc.P1C (39)
Adct-901
Cancer
ADC Therapeutics S.A.P1C (39)
Agen1571
Cancer
Agenus Inc.P1C (39)
alk202
Cancer
Shanghai Allink Biotherapeutics Co., Ltd.P1C (39)
Amg 305
Cancer
AmgenP1C (39)
apn401
Cancer
invIOs GmbHP1C (39)
asc61
Cancer
Ascletis Pharmaceuticals Co., Ltd.P1C (39)
Astx 660
Cancer
Institute of Cancer Research, United KingdomP1C (39)
Atirmociclib
Cancer
OnKure, Inc.P1C (39)
bat6026
Cancer
Bio-Thera SolutionsP1C (39)
bat8006 for
Cancer
Bio-Thera SolutionsP1C (39)
bay2416964
Cancer
BayerP1C (39)
bay2862789
Cancer
BayerP1C (39)
bc3195
Cancer
Biocity Biopharmaceutics Co., Ltd.P1C (39)
Bgb-43395
Cancer
BeOne MedicinesP1C (39)
Bgb-B3227
Cancer
BeiGeneP1C (39)
Bgb-C354
Cancer
BeOne MedicinesP1C (39)
Bms-986360
Cancer
Bristol-Myers SquibbP1C (39)
Bms-986416
Cancer
Bristol-Myers SquibbP1C (39)
br101
Cancer
BioRay Pharmaceutical Co., Ltd.P1C (39)
cd70-targeting car-t cells
Cancer
Chongqing Precision Biotech Co., LtdP1C (39)
Cln-418
Cancer
Harbour BioMed US, Inc.P1C (39)
Cnsi-Fe
Cancer
Sichuan Enray Pharmaceutical Sciences CompanyP1C (39)
Dat-2645
Cancer
Danatlas Pharmaceuticals Co., LtdP1C (39)
ds-1055a
Cancer
Daiichi SankyoP1C (39)
ds-9606a
Cancer
Daiichi SankyoP1C (39)
dsp107
Cancer
Kahr MedicalP1/2C (39)
es009
Cancer
Elpiscience Biopharma Australia Pty. Ltd.P1C (39)
Gamma1 Heavy Chain Humanized (1-453) [Vh (Homo Sapiens Ighv1-3*01 (80.4%)--(Ighd) -Ighj3*01 (92.3%), Cdr-Imgt [8.8.16] (26-33.51-58.97-112)) (1-123) -Homo Sapiens Ighg1*03V, G1M3>G1M17, Ng1M1, Ch1 K120, Ch3 E12, M14, G1V14 Ch2 1.3, A1.2 (Ch1 R120>K (220) (124-221) Hinge 1-15 (222-236), Ch2 L1.3>A (240), L1.2>A (241) (237-346), Ch3 E12 (362), M14 (364) (347-451), Chs (452-453))(124-453)], (226-213')-Disulfide With Kappa Light Chain Humanized (1'-213') [V-Kappa (Homo Sapiens Igkv3-11*01 (82.1%) -Igkj2*02 (100%), Cdr-Imgt [5.3.9] (27-31.49-51.88-96)) (1'-106') -Homo Sapiens Igkc*01 (100%), Km3, A45.1 (152), V101 (190) (107'-213')], Dimer (232-232'':235-235'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Cell Line Cho-K1 Lacking The Glutamine Synthetase (Gs-Ko) Gene, Glycoform Alfa
Cancer
Elpiscience Biopharma, Ltd.P1C (39)
hbm1020
Cancer
Harbour BioMed US, Inc.P1C (39)
hc006
Cancer
HC Biopharma Inc.P1C (39)
hr19024
Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd.P1C (39)
Hrs-1167
Cancer
Jiangsu HengRui Medicine Co., Ltd.P1C (39)
Ibi 360
Cancer
Innovent Biologics (Suzhou) Co. Ltd.P1C (39)
Immunoglobulin G4-Kappa, Anti-[Homo Sapiens Btn1A1 (Butyrophilin Subfamily 1 Member A1)], Humanized Monoclonal Antibody
Cancer
STCube, Inc.P1C (39)
inn805
Cancer
FindCure Biosciences (ZhongShan) Co., Ltd.Early P1C (39)
io-108
Cancer
Immune-Onc TherapeuticsP1C (39)
jzp815
Cancer
Jazz PharmaceuticalsP1C (39)
KN510
Cancer
New Cancer Cure-Bio Co.,Ltd.P1C (39)
KN713
Cancer
New Cancer Cure-Bio Co.,Ltd.P1C (39)
kt-253
Cancer
Kymera Therapeutics, Inc.P1C (39)
Lartesertib
Cancer
EMD Serono Research & Development Institute, Inc.P1C (39)
Mem-288 Intratumoral
Cancer
Memgen, Inc.P1C (39)
Migoprotafib
Cancer
Genentech, Inc.P1C (39)
Showing 751 to 800 of 1,379 assets
PreviousPage 16 of 28Next